Herpes zoster: Risk categories for persistent pain

Journal of Infectious Diseases

Volumn 179, Issue 1, 1999, Pages 9-15

  Whitley, R J ^a,b   Weiss, H L ^a   Soong, S J ^a   Gnann, J W ^a  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; PREDNISONE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HERPES ZOSTER; HUMAN; MAJOR CLINICAL STUDY; MALE; NEURITIS; ORAL DRUG ADMINISTRATION; PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RISK ASSESSMENT; SURVIVAL RATE;

ACTIVITIES OF DAILY LIVING; ACYCLOVIR; AGED; ANTI-INFLAMMATORY AGENTS; ANTIVIRAL AGENTS; FEMALE; HERPES ZOSTER; HUMANS; MALE; MIDDLE AGED; NEURITIS; PAIN; PREDNISONE; QUALITY OF LIFE; RISK FACTORS; TIME FACTORS;

EID: 0032929185     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314562     Document Type: Article

References (16)

1. Weller TH. Varicella and herpes zoster: a perspective and overview. J Infect Dis 1992;166(suppl):S1-6.
2. Huff JC, Bean B, Balfour HH, et al. Therapy of herpes zoster with oral acyclovir. Am J Med 1988;85(suppl 2A):84-9.
3. Harding SP, Porter SM. Oral acyclovir in herpes zoster ophthalmicus. Curr Eye Res 1901;10(suppl)177-82.
4. Morton P, Thomson AN. Oral acyclovir in the treatment of herpes zoster in general practice. NZ Med J 1998;102:93-5.
5. Wood MJ, Ogan P, McKendrick MW, Care CD, McGill JI, Webb EM. Efficacy of oral acyclovir treatment of acute herpes zoster. Am J Med 1988;85(suppl 2A):79-83.
6. Beutner KR, Friedman DJ, Forszpaniak C, Andersen PL, Wood MJ. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother 1996;39:1546-53.
7. Degreef H. Famciclovir, a new oral antiherpes drug: results of the first controlled clinical study demonstrating its efficacy and safety in the treatment of uncomplicated herpes zoster in immunocompetent patients. Famciclovir Herpes Zoster Clinical Study Group. Int J Antimicrob Agents 1994;4:241-6.
8. Tyring S, Barbarash RA, Nahlik JE, et al. Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, plalcebo-controlled trial. Ann Intern Med 1995;123:89-96.
9. Hope-Simpson RE. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med 1965;58:9-20.
10. Choo PW, Galil K, Donahue JG, Walker AM, Spiegelman D, Platt R. Risk factors for post-herpetic neuralgia. Arch Intern Med 1997;157:1217-24.
11. Wood MJ, Kay R, Dworkin RH, Soong SJ, Whitley RJ. Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials. Clin Infect Dis 1996;22:341-7.
12. Dworkin RH, Portenoy RK. Pain and its persistence in herpes zoster. Pain 1996;67:241-51
13. Dworkin RH, Carrington D, Cunningham A, et al. Assessment of pain in herpes zoster: lessons learned from antiviral trials. Antiviral Res 1997;33:73-85.
14. Whitley RJ, Weiss HL, Gnann JW, et al. Acyclovir with and without prednisone for the treatment of herpes zoster: a randomized, placebo-controlled trial. Ann Intern Med 1996;125:376-83.
15. Wood MJ, Johnson RW, McKendrick MW, Taylor J, Mandal BK, Crooks J. A randomized trial of acyclovir for 7 or 21 days with and without prednisone for treatment of acute herpes zoster. N Engl J Med 1994;330:896-900.
16. Beutner KR, Friedman DJ, Forszpaniak C, Andersen PL, Wood MJ. Valaciclovir compared with acyclovir for improved herpes zoster in immunocompetent adults. Antimicrob Agents Chemother 1995;39:1546-53.